Description
Retatrutide is a cutting-edge investigational peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
Retatrutide is a cutting-edge investigational peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
20 in stock
Retatrutide is a cutting-edge investigational peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
Reviews
There are no reviews yet.